Variant report

Variant	esv1851923
Chromosome Location	chr10:28384098-28410989
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:8)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:8 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:28384110..28385653-chr10:28390069..28392151,2	MCF-7	breast:
2	chr10:28397069..28398753-chr10:28400190..28402343,2	K562	blood:
3	chr10:28387058..28389693-chr6:27776467..27779114,2	MCF-7	breast:
4	chr10:28397069..28398753-chr10:28400190..28402343,2	K562	blood:
5	chr10:28372312..28376657-chr10:28391120..28396968,5	K562	blood:
6	chr10:28384110..28385653-chr10:28390069..28392151,2	MCF-7	breast:
7	chr10:28406473..28409563-chr10:28410652..28413187,3	MCF-7	breast:
8	chr10:28406473..28409563-chr10:28410652..28413187,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000203813	chromatin interactions

Extended variants
information (count: 991 )
Associated
traits (count: 43 )

Variant overlapped rSNPs/rCNVs (count:991 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7086023	chr10:28384098-28384099	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs7068015	chr10:28384115-28384116	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs10563132	chr10:28384123-28384124	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs371511281	chr10:28384124-28384125	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs60550562	chr10:28384145-28384146	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs180868395	chr10:28384151-28384152	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs10528025	chr10:28384152-28384153	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs11006858	chr10:28384167-28384168	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs570940003	chr10:28384169-28384170	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs528550160	chr10:28384197-28384198	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs546664194	chr10:28384231-28384232	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs568347112	chr10:28384265-28384266	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs535642232	chr10:28384332-28384333	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs550906745	chr10:28384333-28384334	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs569405617	chr10:28384354-28384355	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs537061953	chr10:28384356-28384357	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs373736178	chr10:28384361-28384362	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs187362595	chr10:28384369-28384370	Weak transcription Flanking Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs375403628	chr10:28384416-28384417	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs576896411	chr10:28384418-28384419	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs534738241	chr10:28384431-28384432	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs553089434	chr10:28384448-28384449	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs192206370	chr10:28384514-28384515	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs148700637	chr10:28384521-28384522	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs144510522	chr10:28384533-28384534	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs575413614	chr10:28384548-28384549	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs183150380	chr10:28384566-28384567	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs79546972	chr10:28384571-28384572	Weak transcription Flanking Active TSS Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs564351468	chr10:28384605-28384606	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs528450037	chr10:28384757-28384758	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs185897140	chr10:28384862-28384863	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs561841810	chr10:28384943-28384944	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs11006859	chr10:28384965-28384966	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
34	rs555888880	chr10:28385001-28385002	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs373308661	chr10:28385057-28385058	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs534236261	chr10:28385058-28385059	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs190306433	chr10:28385068-28385069	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs182690439	chr10:28385069-28385070	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs374751505	chr10:28385087-28385088	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs139671913	chr10:28385095-28385096	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs145202109	chr10:28385105-28385106	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs147699779	chr10:28385147-28385148	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs188213048	chr10:28385160-28385161	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs574542414	chr10:28385173-28385174	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs535659934	chr10:28385174-28385175	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs556847477	chr10:28385238-28385239	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs372387791	chr10:28385266-28385267	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs192455408	chr10:28385319-28385320	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs74903316	chr10:28385339-28385340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs140979615	chr10:28385363-28385364	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:43)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	21364760	CNVD
abnormal development	18461090	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22048815	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	22341455	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:202 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:28347000-28412200	Weak transcription	Left Ventricle	heart
2	chr10:28347000-28414600	Weak transcription	Sigmoid Colon	Sigmoid Colon
3	chr10:28364800-28392000	Weak transcription	Gastric	stomach
4	chr10:28364800-28416600	Weak transcription	Pancreas	Pancrea
5	chr10:28367800-28420200	Weak transcription	Rectal Smooth Muscle	rectum
6	chr10:28376000-28438400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
7	chr10:28376600-28416600	Weak transcription	Fetal Intestine Large	intestine
8	chr10:28376800-28392000	Weak transcription	Esophagus	oesophagus
9	chr10:28377600-28384200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
10	chr10:28377800-28388200	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
11	chr10:28378000-28418400	Weak transcription	Skeletal Muscle Female	skeletal muscle
12	chr10:28378400-28386400	Weak transcription	Primary hematopoietic stem cells	blood
13	chr10:28378600-28396200	Weak transcription	Stomach Smooth Muscle	stomach
14	chr10:28378600-28400800	Weak transcription	HSMM	muscle
15	chr10:28378600-28407400	Weak transcription	Duodenum Smooth Muscle	Duodenum
16	chr10:28378600-28412800	Weak transcription	Primary T helper naive cells from peripheral blood	blood
17	chr10:28378600-28425600	Weak transcription	Colon Smooth Muscle	Colon
18	chr10:28378800-28396400	Weak transcription	Primary T cells fromperipheralblood	blood
19	chr10:28378800-28407400	Weak transcription	Primary T helper cells PMA-I stimulated	--
20	chr10:28378800-28408400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
21	chr10:28379000-28407000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
22	chr10:28379200-28386000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
23	chr10:28379200-28391800	Weak transcription	Aorta	Aorta
24	chr10:28379200-28394800	Weak transcription	Primary neutrophils fromperipheralblood	blood
25	chr10:28379200-28395600	Weak transcription	Primary monocytes fromperipheralblood	blood
26	chr10:28379200-28406600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
27	chr10:28379200-28416600	Weak transcription	Fetal Intestine Small	intestine
28	chr10:28379800-28407800	Weak transcription	Primary T helper cells fromperipheralblood	blood
29	chr10:28380000-28396000	Weak transcription	Breast Myoepithelial Primary Cells	Breast
30	chr10:28380000-28398400	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
31	chr10:28382200-28384200	Weak transcription	HUVEC	blood vessel
32	chr10:28383600-28384800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr10:28383600-28391600	Weak transcription	Primary T cells from cord blood	blood
34	chr10:28383600-28394800	Weak transcription	Monocytes-CD14+_RO01746	blood
35	chr10:28384200-28384400	Enhancers	HUVEC	blood vessel
36	chr10:28384200-28384600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr10:28384400-28384600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
38	chr10:28384400-28384800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr10:28384400-28384800	Active TSS	Osteobl	bone
40	chr10:28384400-28385000	Active TSS	Muscle Satellite Cultured Cells	--
41	chr10:28384400-28385200	Flanking Active TSS	HUVEC	blood vessel
42	chr10:28384400-28385400	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr10:28384600-28384800	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
44	chr10:28384600-28384800	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr10:28384600-28385000	Active TSS	NHDF-Ad	bronchial
46	chr10:28384800-28385000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
47	chr10:28384800-28385000	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
48	chr10:28385200-28385400	Enhancers	HUVEC	blood vessel
49	chr10:28386000-28386200	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
50	chr10:28386200-28394400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links